Document Detail


Immune thrombocytopenic purpura in pregnancy.
MedLine Citation:
PMID:  17934366     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: This review assesses the need for revision of the present guidelines for immune thrombocytopenic purpura in pregnancy based on evidence-based data from published articles of relevance. RECENT FINDINGS: The American Society of Hematology (ASH) and British Committee for Standards in Haematology (BCSH) guidelines indicate that at platelet counts below 70,000 or 80,000/microl, respectively, causes of thrombocytopenia other than gestational thrombocytopenia should be considered. The ASH guidelines indicate that for severe thrombocytopenia or thrombocytopenic bleeding in the third trimester, intravenous immunoglobulin is an appropriate first-line agent. No consensus was reached concerning the use of intravenous immunoglobulin or corticosteroids as first-line therapy at other gestational periods. Splenectomy is considered acceptable for patients with refractory immune thrombocytopenic purpura and severe thrombocytopenia with bleeding only in the second trimester. Laparoscopic splenectomy can be safely performed during pregnancy. The BCSH guidelines are consistent with contemporary practice in recommending that the mode of delivery of a pregnant patient with immune thrombocytopenic purpura should be determined based on maternal indications. Screening of articles published since the formulation of the BCSH guidelines in 2003 did not reveal new data that would lead to significant revisions in the guidelines. SUMMARY: Though outdated in some aspects, the ASH and BCSH guidelines still provide a useful framework for management of pregnant patients with immune thrombocytopenic purpura.
Authors:
Terry Gernsheimer; Keith R McCrae
Related Documents :
21306326 - Intrauterine insemination versus timed intercourse with clomiphene citrate in polycysti...
19190806 - Pregnancy-associated thrombotic thrombocytopenic purpura.
18239006 - Transient severe fetal heart rate abnormalities in a pregnancy complicated by thromboti...
21077156 - Clinical implications of intra- and inter-observer reproducibility of first trimester m...
21481146 - Transvaginal removal of ectopic pregnancy tissue and repair of uterine defect for caesa...
17661756 - Review article: reproduction in the patient with inflammatory bowel disease.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in hematology     Volume:  14     ISSN:  1065-6251     ISO Abbreviation:  Curr. Opin. Hematol.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-10-15     Completed Date:  2007-12-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9430802     Medline TA:  Curr Opin Hematol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  574-80     Citation Subset:  IM    
Affiliation:
University of Washington and Puget Sound Blood Center, Seattle, Washington 98104, USA. bldbuddy@u.washington.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Cortex Hormones / therapeutic use*
Delivery, Obstetric
Female
Gestational Age
Great Britain
Hematology
Hemorrhage / diagnosis,  therapy
Humans
Immunoglobulins, Intravenous / therapeutic use*
Immunologic Factors / therapeutic use*
Laparoscopy
Platelet Count
Practice Guidelines as Topic
Pregnancy
Pregnancy Complications, Hematologic / diagnosis,  therapy*
Pregnancy Outcome
Pregnancy Trimester, Third
Purpura, Thrombocytopenic, Idiopathic / diagnosis,  therapy*
Severity of Illness Index
Societies, Medical
Splenectomy*
United States
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Immunoglobulins, Intravenous; 0/Immunologic Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Secondary immune thrombocytopenic purpura.
Next Document:  Romantic attachment in patients with mood and anxiety disorders.